Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Schizophrenia is one of the most debilitating and costly illnesses worldwide. First-generation antipsychotics such as chlorpromazine and haloperidol succeeded in controlling the positive symptoms of schizophrenia, but had significant extrapyramidal effects that led to the search for new agents and the release of second-generation (or atypical) antipsychotics. These drugs had a lower risk of adverse motor symptoms. Therapeutic drug monitoring has become a useful tool to optimize schizophrenia treatment and HPLC-MS/MS has been considered the primary technique to monitor antipsychotics. This review comprises three sections: schizophrenia pathophysiology and treatment; recent advances in LC-MS/MS methods designed to measure levels of antipsychotics and their metabolites in plasma samples (selectivity, matrix effect and sensitivity); and the importance of therapeutic drug monitoring.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4155/bio-2018-0155 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of injection solvent composition on 90 pesticides by LC-MS/MS: A data-driven framework for initial method development.
J Chromatogr A
September 2025
Agro-Food Technology and Quality Laboratory, Regional Center of Agricultural Research of Meknes, National Institute of Agricultural Research, Rabat, Morocco. Electronic address:
The composition of the injection solvent is a critical, yet often underestimated, parameter in liquid chromatography-tandem mass spectrometry (LC-MS/MS). This study systematically evaluates the influence of injection solvent on the analysis of 90 pesticides by comparing mixtures of acetonitrile (ACN) with water and buffered mobile phase A (5 mM ammonium formate, 0.1% formic acid) across various ratios (10/90 to 50/50, v/v).
View Article and Find Full Text PDFOrganophosphate triesters （tri-OPEs） are synthetic phosphate derivatives that are primarily used as flame retardants and plasticizers. Tri-OPEs have become significant aquatic contaminants owing to their large production volumes and wide range of applications. Organophosphate diesters （di-OPEs） are closely related to tri-OPEs.
View Article and Find Full Text PDFRecent Advances in Bioanalytical Methods for Quantification and Pharmacokinetic Analyses of Antibody-Drug Conjugates.
AAPS J
September 2025
Clinical Pharmacology Laboratory, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, Maryland, 20892, USA.
Antibody-drug conjugates (ADCs) represent a rapidly expanding class of therapeutics, uniquely combining the specificity of monoclonal antibodies with the potency of cytotoxic small-molecule payloads. Due to their inherent structural complexity and heterogeneous composition, accurate characterization and quantification of ADCs pose significant bioanalytical challenges. This review discusses recent advancements in bioanalytical methodologies, including ligand binding assays (LBAs), liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based approaches, and emerging hybrid LBA-LC-MS/MS platforms.
View Article and Find Full Text PDFComprehensive carbohydrate profiling by mass spectrometry for the valorization of pomegranate side streams.
Food Chem
August 2025
Department of Food Science and Technology, University of California, Davis, Davis, CA 95616, USA. Electronic address:
Pomegranate processing generates large quantities of pomace and mesocarp, yet their carbohydrate composition remains largely unexplored. Here, we applied comprehensive mass spectrometry-based profiling to characterize monosaccharides, oligosaccharides, and polysaccharides from these side streams. Fructose and glucose dominated the free sugar fraction in both tissues.
View Article and Find Full Text PDFOvercoming bioanalytical challenges during the development of risdiplam for the treatment of spinal muscular atrophy.
Bioanalysis
September 2025
Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Aims: Risdiplam is a small molecule approved for the treatment of spinal muscular atrophy (SMA). The drug and its major metabolite had to be measured in plasma and tissue from several animal species and in human plasma and urine. Bioanalytical challenges including light sensitivity, instability, carryover, nonspecific binding, and complex tissue analysis, had to be overcome.
View Article and Find Full Text PDF